HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Inhaled Drug Delivery

Inhaled therapy is determined by the needs of individual therapeutic interventions. Inhalation therapy has been used for thousands of years in many forms and applications. Inhaler design has remained mostly unchanged over the last decade; however some aspects have resulted in advancements that provide new disease treatment options. The structure and design of an inhaler have a significant impact on the quantity of aerosol that is deposited in the lungs. An ideal inhaler should deliver precise and regular doses to a specific area of the lungs whilst maintaining drug stability. It's also ideal if the devices are compact and simple enough for patients to operate.

  • Future needs for inhaled drug delivery
  • Innovation in nebulized therapy
  • Nebulizers – modern advances
  • Development of propellant-free MDIs
  • Aerosol-mediated delivery of drugs
  • Triple combination inhalers – the challenges
  • Functional respiratory imaging
Committee Members
Speaker at Global Conference on Pharmaceutics and Novel Drug Delivery Systems 2025 - John K Maesaka

John K Maesaka

NYU Langone Hospital Long Island, United States
Speaker at Global Conference on Pharmaceutics and Novel Drug Delivery Systems 2025 - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
Speaker at Global Conference on Pharmaceutics and Novel Drug Delivery Systems 2025 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Speaker at Global Conference on Pharmaceutics and Novel Drug Delivery Systems 2025 - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
Tags

Submit your abstract Today

Watsapp